Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation

被引：28
|
作者：
Torre-Cisneros, J
De la Mata, M
Pozo, JC
Serrano, P
Briceño, J
Solórzano, G
Miño, G
Pera, C
Sánchez-Guijo, P
机构：
[1] Hosp Univ Reina Sofia, Infect Dis Sect, Cordoba, Spain
[2] Hosp Univ Reina Sofia, Liver Transplantat Unit, Cordoba, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 1999年 / 29卷 / 04期
关键词：
D O I：
10.1086/520432
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We conducted a prospective, randomized clinical trial among liver transplant patients to assess the efficacy and safety of weekly sulfadoxine/pyrimethamine compared with daily trimethoprimsulfamethoxazole in the prevention of Pneumocystis carinii pneumonia, The studied drugs were given during 6 months after transplantation. One hundred twenty patients were included. None of the 60 patients receiving weekly sulfadoxine/pyrimethamine developed Pneumocystis carinii pneumonia, whereas two cases (3%) developed among the 60 patients who received trimethoprimsulfamethoxazole. For both patients, the studied medication had been discontinued several weeks earlier because of adverse effects. No differences were observed in the incidence of adverse effects. We conclude that weekly sulfadoxine/pyrimethamine is as effective and safe as is daily trimethoprim-sulfamethoxazole in the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
引用
收藏
页码：771 / 774
页数：4
相关论文
共 50 条
  • [41] Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS - A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine
    Safrin, S
    Finkelstein, DM
    Feinberg, JD
    Frame, P
    Simpson, G
    Wu, A
    Cheung, T
    Soeiro, R
    Hojczyk, P
    Black, JR
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (09) : 792 - +
  • [42] Prophylaxis against Pneumocystis jirovecii pneumonia and toxoplasmosis with low-dose Trimethoprim-sulfamethoxazole (cotrimoxazole 20/100 mg) in heart transplant patients. The PAPTO-LOCO observational comparative study
    Aggoun, Dahlia
    Verdonk, Constance
    Bleibtreu, Alexandre
    Fekkar, Arnaud
    Houze, Sandrine
    Zafrani, Lara
    Desire, Eva
    Varnous, Shaida
    Leprince, Pascal
    Coutance, Guillaume
    Lescroart, Mickael
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025,
  • [43] Small-Dose Trimethoprim-Sulfamethoxazole Prevents Pneumocystis Jiroveci Pneumonia in B-Cell Lymphoma Patients Receiving Chemotherapy: Analysis of a Randomized Controlled Clinical Trial
    Liu, Chunxiao
    Zhang, Xuewu
    Zhu, Yanan
    Xiao, Feng
    Lv, Yunfei
    Ye, Xingnong
    Li, Xia
    Wei, Juying
    Wang, Huafeng
    Zhou, Yile
    Tong, Hongyan
    Zhou, Xinping
    Yang, Chunmei
    Mao, Liping
    Zhou, De
    Zhu, Li
    Zheng, Xiaolong
    Ye, Li
    You, Liangshun
    Jin, Jie
    Yu, Wenjuan
    BLOOD, 2023, 142
  • [44] Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial
    Abe, Yoshiyuki
    Fujibayashi, Kazutoshi
    Nishizakik, Yuji
    Yanagisawa, Naotake
    Nojiri, Shuko
    Nakano, Soichiro
    Tada, Kurisu
    Yamaji, Ken
    Tamura, Naoto
    ACTA MEDICA OKAYAMA, 2019, 73 (01) : 85 - 89
  • [45] Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ
    Leoung, GS
    Stanford, JF
    Giordano, MF
    Stein, A
    Torres, RA
    Giffen, CA
    Wesley, M
    Sarracco, T
    Cooper, EC
    Dratter, V
    Smith, JJ
    Frost, KR
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08): : 992 - 997
  • [46] Twice Weekly Vs. Thrice Weekly Low-Dose Prophylactic Factor VIII Therapy in Children with Hemophilia A: An Open Label Randomized Trial
    Gomber, Sunil
    Singhal, Gorika
    Dewan, Pooja
    Upreti, Lalendra
    Sikka, Meera
    JOURNAL OF TROPICAL PEDIATRICS, 2022, 68 (03)
  • [47] A prospective randomized trial comparing the toxicity and safety of atovaquone versus trimethoprim/sulfarieteioxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby, C
    McAfee, SL
    Sackstein, R
    Finkelstein, D
    Fishman, JA
    Spitzer, TR
    BLOOD, 1998, 92 (10) : 278A - 278A
  • [48] Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study
    Nakashima, Kei
    Aoshima, Masahiro
    Nakashita, Tamao
    Hara, Masahiko
    Otsuki, Ayumu
    Noma, Satoshi
    Misawa, Masafumi
    Otsuka, Yoshihito
    Motojima, Shinji
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (06) : 810 - 820
  • [49] Prophylaxis of Toxoplasmosis (TXO) reactivation after allogeneic Stem Cell Transplantation (SCT): a prospective randomized trial comparing Trimethoprim/Sulfamethoxazole (TMP/SMX) with Pyrimethamine/Dapsone (PYR/DPS)
    Trenschel, R
    Basoglu, S
    Ottinger, HD
    Beelen, DW
    Schaefer, UW
    Runde, V
    BONE MARROW TRANSPLANTATION, 2001, 27 : S200 - S200
  • [50] Which trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settings
    Recht, Judith
    Evans, Terry John
    Chansamouth, Vilada
    Phommasone, Koukeo
    Mayxay, Mayfong
    Ashley, Elizabeth A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2025, 31 (01) : 13 - 17
12345